JPH0614746A - Health beverage - Google Patents
Health beverageInfo
- Publication number
- JPH0614746A JPH0614746A JP4196545A JP19654592A JPH0614746A JP H0614746 A JPH0614746 A JP H0614746A JP 4196545 A JP4196545 A JP 4196545A JP 19654592 A JP19654592 A JP 19654592A JP H0614746 A JPH0614746 A JP H0614746A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- drinking
- rutin
- quercetin
- health drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 64
- 235000013361 beverage Nutrition 0.000 title abstract description 17
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 62
- 229930182470 glycoside Natural products 0.000 claims abstract description 51
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 50
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 50
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 50
- 229960001285 quercetin Drugs 0.000 claims abstract description 50
- 235000005875 quercetin Nutrition 0.000 claims abstract description 50
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 46
- 229940069445 licorice extract Drugs 0.000 claims abstract description 43
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 27
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 27
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 23
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 23
- 239000011718 vitamin C Substances 0.000 claims abstract description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000011575 calcium Substances 0.000 claims abstract description 14
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000002338 glycosides Chemical class 0.000 claims abstract description 13
- 239000011777 magnesium Substances 0.000 claims abstract description 13
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 12
- 239000011701 zinc Substances 0.000 claims abstract description 12
- 235000015165 citric acid Nutrition 0.000 claims abstract description 10
- -1 quercetin glycoside Chemical class 0.000 claims description 38
- 239000004378 Glycyrrhizin Substances 0.000 claims description 34
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 34
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 34
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 34
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 34
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 34
- 229910021645 metal ion Inorganic materials 0.000 claims description 19
- 150000007524 organic acids Chemical class 0.000 claims description 18
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 208000006558 Dental Calculus Diseases 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract description 57
- 230000035622 drinking Effects 0.000 abstract description 52
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract description 43
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract description 43
- 235000005493 rutin Nutrition 0.000 abstract description 43
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract description 43
- 229960004555 rutoside Drugs 0.000 abstract description 43
- 206010025482 malaise Diseases 0.000 abstract description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 35
- 206010019133 Hangover Diseases 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 31
- 239000000284 extract Substances 0.000 abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 20
- 239000004480 active ingredient Substances 0.000 abstract description 14
- 230000004060 metabolic process Effects 0.000 abstract description 11
- 239000008213 purified water Substances 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 7
- 241000237502 Ostreidae Species 0.000 abstract description 6
- 235000020636 oyster Nutrition 0.000 abstract description 6
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 150000001455 metallic ions Chemical class 0.000 abstract 2
- 230000003902 lesion Effects 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract 1
- 235000021271 drinking Nutrition 0.000 description 50
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 41
- 235000019441 ethanol Nutrition 0.000 description 32
- 210000003000 inclusion body Anatomy 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
- 229960005069 calcium Drugs 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 240000008620 Fagopyrum esculentum Species 0.000 description 10
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000002195 synergetic effect Effects 0.000 description 8
- 241000202807 Glycyrrhiza Species 0.000 description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 229940010454 licorice Drugs 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 108700012359 toxins Proteins 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 6
- 239000001527 calcium lactate Substances 0.000 description 6
- 235000011086 calcium lactate Nutrition 0.000 description 6
- 229960002401 calcium lactate Drugs 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 235000011147 magnesium chloride Nutrition 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 230000020411 cell activation Effects 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 210000005259 peripheral blood Anatomy 0.000 description 5
- 239000011886 peripheral blood Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 229940097043 glucuronic acid Drugs 0.000 description 4
- 231100000234 hepatic damage Toxicity 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008818 liver damage Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000003228 microsomal effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 150000003305 rutin Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、ケルセチン配糖体と2
価の金属イオンと甘草抽出物を必須成分とした健康飲料
であり、飲酒の際の肝臓におけるアルコール代謝機能を
促進し、生体のイオンバランスを正常に保つことによっ
て飲酒に伴う酔い過ぎ、悪酔い、二日酔いの予防及び防
止等に有効な健康飲料に関する。The present invention relates to quercetin glycosides and 2
It is a health drink that contains valent metal ions and licorice extract as essential ingredients, promotes alcohol metabolism function in the liver during drinking, and keeps the ion balance of the living body normal, resulting in excessive sickness, sickness, and hangover associated with drinking The present invention relates to a health drink effective for prevention and prevention of
【0002】[0002]
【従来の技術】ケルセチン配糖体として、ルチンがエン
ジュやそばに含有されており、このルチンは主として毛
細血管性出血の治療に用いられる上、高血圧症、毛細血
管拡張症、そのほか欠陥脆弱による各種出血の治療に有
効であると言われている。2. Description of the Related Art Rutin, which is a quercetin glycoside, is contained in Enju and buckwheat. This rutin is mainly used for the treatment of capillarity bleeding, and it is also associated with hypertension, telangiectasia, and various other vulnerable defects. It is said to be effective in treating bleeding.
【0003】又、カルシウム、マグネシウム及び亜鉛等
のミネラル成分は、骨、歯の構成成分であり、体内有機
化合物の成分になる他、体液イオンの浸透圧の保持、酸
アルカリ平衡、筋肉神経の刺激伝達などの生理調整物質
であり、生体にとって何れも重要な物質である。Mineral components such as calcium, magnesium and zinc are constituent components of bones and teeth, and become components of organic compounds in the body, and also maintain osmotic pressure of body fluid ions, acid-alkali balance, and stimulation of muscle nerves. It is a substance that regulates physiology such as transmission, and is an important substance for the living body.
【0004】ところで、飲酒に起因するアルコールと人
体との関係、とりわけ飲酒による悪酔いや二日酔いは酒
をたしなむものにとって必ずと言ってよい程、誰もが体
験するものである。この悪酔いや二日酔いは飲酒の前や
飲酒と同時に食物を食しておくことによって、胃壁を保
護しアルコールの吸収を遅延させる等の効果によって、
いくぶん緩和されることが知られているが十分な対策と
なりうるものでない。By the way, the relationship between alcohol and the human body caused by drinking, especially the sickness and hangover caused by drinking, is something that anyone who enjoys drinking is sure to experience it. For this sickness and hangover, by eating food before drinking and at the same time as drinking, due to effects such as protecting the stomach wall and delaying absorption of alcohol,
It is known to be somewhat mitigated, but it cannot be a sufficient countermeasure.
【0005】又、アルコールは、体内で最終的に炭酸ガ
スと水とに分解されるが、その間、二日酔いや悪酔いの
原因と言われているアセトアルデヒドの生成や、電解質
バランス更にプロスタグランジンへの関与等が指摘され
ているだけでなく、脂質代謝、アミノ酸蛋白質代謝、消
化器官、脳神経等の多方面に影響を与えていると言われ
ている。Alcohol is finally decomposed into carbon dioxide gas and water in the body, during which time acetaldehyde, which is said to be the cause of hangover and sickness, is involved, and its involvement in electrolyte balance and prostaglandins. It has been pointed out that it influences various aspects such as lipid metabolism, amino acid protein metabolism, digestive organs, cranial nerves, etc.
【0006】更に、一般に、飲酒の際、胃腸等の負担に
よって食事が減退したり或いは食事がおろそかとなって
胃や腸などの消化器官の負担が大となり、この結果、体
力の回復に長時間を要したり、つまり二日酔いの原因と
なったり、栄養のバランスが崩れ、種々の問題が指摘さ
れている。[0006] Further, in general, when drinking alcohol, meals are reduced due to gastrointestinal burden, or meals are neglected, resulting in a heavy burden on digestive organs such as stomach and intestines. As a result, recovery of physical strength takes a long time. It has been pointed out that various problems have been pointed out, that is, it causes a hangover, imbalances nutritional balance.
【0007】 二日酔い、悪酔いの予防及び対応の食
品又は医薬品として、飲酒に伴う胃や腸の機能低下の改
善を目的として、健胃作用や整腸作用を期待した胃腸薬
や、酵母食品、カキ肉エキス、柿タンニン等が提案され
ている。[0007] As a food or medicine for the prevention of hangover and sickness, and for the purpose of improving the deterioration of the functions of the stomach and intestines associated with drinking, gastrointestinal drugs, yeast foods, oyster meat, which are expected to have stomachic and intestinal function Extracts, persimmon tannins, etc. have been proposed.
【0008】 各種ミネラルやビタミン、その他生薬
等の種々の成分を加えた、スポーツドリンクや滋養強壮
を目的とした健康飲料も広く飲用されている。[0008] Sports drinks and health drinks for the purpose of nourishing and toning, which are added with various components such as various minerals, vitamins and other crude drugs, are also widely consumed.
【0009】更に、 甘草抽出物を成分とする、肝臓
機能を強化し保護する目的の医薬品も提供されている。Further, there is also provided a medicine containing a licorice extract as a component for the purpose of enhancing and protecting liver function.
【0010】[0010]
【発明が解決しようとする課題】しかしながら、上記の
ものには以下に述べる課題がある。即ち、上記のもの
においては、酵母食品、カキ肉エキス及び柿タンニンな
どを摂取することにより、アルコール代謝が促進される
とともにアルコールによる負担が緩和され、ある程度の
効果が期待できるものの二日酔いや悪酔いに対して充分
なものと言えるものではない。However, the above problems have the following problems. That is, in the above, by ingesting yeast foods, oyster meat extract, persimmon tannin, etc., alcohol metabolism is promoted and the burden of alcohol is alleviated, but for some effects such as hangover and hangover Is not enough.
【0011】又、上記のスポーツドリンクや健康飲料
は、各種ミネラルを補給し体調を整える作用を有する
が、飲酒に対応する目的のものでもなくその効果を期待
するものでもない上、二日酔いや悪酔いに対しては全く
効果が期待できないのである。The above-mentioned sports drinks and health drinks have the effect of replenishing various minerals and adjusting their physical condition, but they are not intended to cope with drinking and are not expected to have their effects, and also to prevent hangovers and hangovers. On the other hand, no effect can be expected.
【0012】上記のものは、甘草に含まれるグリチル
リチンが体内でグルクロン酸を生じて解毒等の作用を表
し、肝臓を保護しアルコールの代謝を促進させるもので
あり、飲酒に対してある程度の効果が期待できるが、充
分なものではなかった。[0012] The above is one in which glycyrrhizin contained in licorice produces glucuronic acid in the body and exhibits an action such as detoxification, protects the liver and promotes metabolism of alcohol, and has some effect on drinking alcohol. I can expect it, but it was not enough.
【0013】本発明は、上記技術的課題に鑑み、完成さ
れたものである。即ち、本発明者は、そばの若葉を有効
成分とする機能性食品が、飲酒による酔い過ぎ、悪酔い
及び二日酔いに対して大変優れた効果があることから、
そばの若葉の成分を鋭意研究し、その成分であるルチン
とカルシウム、マグネシウム等のミネラルがグリチルリ
チンを含む甘草抽出物と相乗的に働いて、飲酒による酔
い過ぎ、悪酔い及び二日酔いの予防や対応に効果がある
ことを見い出したのである。The present invention has been completed in view of the above technical problems. That is, the present inventor, the functional food containing young leaves of buckwheat as an active ingredient, is very effective against drunkenness due to drinking, hangover and hangover,
Carefully researching the components of young leaves of buckwheat, and its components rutin and minerals such as calcium and magnesium work synergistically with licorice extract containing glycyrrhizin, and it is effective in preventing and responding to drunkenness, hangover and hangover It was discovered that there was.
【0014】そして、これらの有効成分を水溶液とし、
飲酒に対応して飲用する場合、この有用な成分のうち、
ルチン及びグリチルリチンは水に難溶の成分であり、飲
酒対応健康飲料とするには問題がある。Then, these active ingredients are made into an aqueous solution,
Of this useful ingredient when drinking in response to drinking,
Rutin and glycyrrhizin are poorly soluble components in water, and there is a problem in making them a health drink for drinking.
【0015】そこで、本発明者は、毛細血管性出血や各
種出血の治療や高血圧に有効であると言われ、更に酸化
防止効果のあるケルセチンの配糖体を含み、又、体液の
浸透圧の保持や酸アルカリ平衡等の電解質バランスに影
響を与え、しかも筋肉神経の刺激伝達などの生理機能調
整物質であるミネラルのうち、ケルセチン配糖体と錯体
を形成する等の相互作用を有する2価の金属イオンであ
る、カルシウム、マグネシウム、亜鉛を含有してなるも
のを検討し、これらのミネラルは、生体にとって不可欠
なものであるが、特に飲酒による生体の諸機能の変調の
回復に重要な役割を果すことを見い出した。Therefore, the present inventor is said to be effective for the treatment of capillary bleeding and various bleeding and for high blood pressure, and further contains a glycoside of quercetin which has an antioxidant effect, and further Among the minerals that affect retention and electrolyte balance such as acid-alkali equilibrium, and are physiological function-regulating substances such as muscular nerve stimulation transmission, divalent divalent compounds that interact with quercetin glycosides to form complexes We examined substances containing the metal ions calcium, magnesium, and zinc, and these minerals are indispensable to the living body, but in particular, they play an important role in recovering the modulation of various functions of the living body by drinking alcohol. I have found that I can do it.
【0016】本発明は、ケルセチンの配糖体と、2価の
金属イオン及びグリチルリチンを含む安全な食品添加物
である甘草抽出物を必須成分とすることにより、この甘
草抽出物はアルコール代謝を促進してその負担を緩和
し、且つ肝障害抑制作用やミクロゾーム系の代謝酵素、
又は細胞膜等に作用してエタノールやアセトアルデヒド
による障害を抑制する機能があり、2価の金属イオンで
ある、カルシウム、マグネシウム、亜鉛等との相乗効果
によって、飲酒に伴う酔い過ぎ、悪酔い、二日酔いの予
防や防止を効果的に図り、しかも、安全でいつでも、飲
酒前或いは飲酒直前や飲酒後においても手軽に飲用しう
る健康飲料を提供することを目的としたものである。According to the present invention, a licorice extract, which is a safe food additive containing a quercetin glycoside, a divalent metal ion and glycyrrhizin, is an essential component, and the licorice extract promotes alcohol metabolism. To relieve the burden, and to suppress liver damage and microsomal metabolic enzymes,
Or, it acts on cell membranes and the like to suppress damage caused by ethanol and acetaldehyde, and by the synergistic effect with calcium, magnesium, zinc, etc., which are divalent metal ions, prevention of excessive sickness, sickness, and hangover associated with drinking It is an object of the present invention to provide a healthy beverage that is effective for prevention and is safe, and that can be easily consumed at any time before, immediately before or after drinking.
【0017】更に、本発明においては、各有効成分とし
て水溶性の成分を用いたり、各有効成分を水に可溶化す
ることによって、有用な健康飲料を提供することを目的
とするものであり、各有効成分の摂取必要量は、通常の
医薬品としての常用量に比較して、極めて少量で飲酒に
伴う酔い過ぎ、悪酔い、二日酔いの予防や防止効果を発
現するものである。Further, in the present invention, it is an object of the present invention to provide a useful health drink by using a water-soluble component as each active ingredient or solubilizing each active ingredient in water. The amount of each active ingredient required to be ingested is extremely small as compared with the usual dose as a usual drug, and the effect of preventing or preventing excessive sickness, sickness and hangover associated with drinking is expressed.
【0018】[0018]
【課題を解決するための手段】上記目的を達成するため
に、本発明の健康飲料は、以下の技術的手段を講じたも
のである。In order to achieve the above object, the health drink of the present invention has the following technical means.
【0019】即ち、本発明の健康飲料においては、ケル
セチンの配糖体と、2価の金属イオン及び甘草抽出物を
必須成分とするものである。以下、本発明を詳細に説明
する。That is, in the health drink of the present invention, quercetin glycoside, divalent metal ion and licorice extract are essential components. Hereinafter, the present invention will be described in detail.
【0020】本発明に用いられるケルセチンの配糖体と
しては特に限定されるものではないが、水溶性のケルセ
チンの配糖体、即ち、水溶性ルチン或いは、シクロデキ
ストリンによって包摂されているケルセチンの配糖体が
挙げられる。The glycoside of quercetin used in the present invention is not particularly limited, but the glycoside of water-soluble quercetin, that is, water-soluble rutin or quercetin included by cyclodextrin. Examples include glycosides.
【0021】ケルセチンの配糖体としては、水溶性ルチ
ンとして、グルコース数が複数個からなる糖を付加した
α−グルコシルルチンが挙げられる。又、常法によって
得られるルチンのシクロデキストリンの包摂化合物を用
いてもよいのである。As the glycoside of quercetin, as water-soluble rutin, α-glucosyl rutin to which a sugar having a plurality of glucose is added can be mentioned. Also, an inclusion compound of rutin cyclodextrin obtained by a conventional method may be used.
【0022】ところで、ケルセチンの配糖体のルチン
は、エンジュやそば、柑橘類に含まれているものであ
り、極めて安全性の高いものである。By the way, rutin, which is a glycoside of quercetin, is contained in Enju, buckwheat, and citrus fruits, and is extremely safe.
【0023】又、本発明の健康飲料においては、上記ケ
ルセチン配糖体と、2価の金属イオン及び甘草抽出物を
必須成分とするものである。In the health drink of the present invention, the quercetin glycoside, the divalent metal ion and the licorice extract are essential components.
【0024】この2価の金属イオンとしてはカルシウ
ム、マグネシウム又は亜鉛のうち少なくとも1種が挙げ
られる。The divalent metal ion includes at least one of calcium, magnesium and zinc.
【0025】本発明において、カルシウム、マグネシウ
ム又は亜鉛が、健康飲料中で、イオンの形で存在できる
ものであれば、特に限定されるものではないが、一般に
食品として使用されるものが安全性の点から好ましい。In the present invention, calcium, magnesium or zinc is not particularly limited as long as it can exist in the form of ions in health drinks, but those generally used as foods are safe. It is preferable from the point.
【0026】即ち、カルシウム化合物としては溶解度が
0.1g/100ml以上のものであれば特に限定され
るものではなく、具体的には、例えば乳酸カルシウム、
グルコン酸カルシウム、パントテン酸カルシウム、硫酸
カルシウム、塩化カルシウム、プロピオン酸カルシウ
ム、水酸化カルシウム、リン酸カルシウム、及び天然の
カルシウム源である骨粉や貝の殻、卵の殻等をイオン化
し水溶性にしたものなどが挙げられる。That is, the calcium compound is not particularly limited as long as it has a solubility of 0.1 g / 100 ml or more, and specifically, for example, calcium lactate,
Calcium gluconate, calcium pantothenate, calcium sulphate, calcium chloride, calcium propionate, calcium hydroxide, calcium phosphate, as well as ionized water sources such as bone meal, shellfish and egg shells, which are natural sources of calcium. Is mentioned.
【0027】又、マグネシウム化合物としては溶解度が
0.1g/100ml以上のものであれば特に限定され
るものではなく、具体的には、例えば塩化マグネシウ
ム、硫酸マグネシウム、酸化マグネシウムやステアリン
酸マグネシウム等が挙げられる。The magnesium compound is not particularly limited as long as it has a solubility of 0.1 g / 100 ml or more, and specific examples thereof include magnesium chloride, magnesium sulfate, magnesium oxide and magnesium stearate. Can be mentioned.
【0028】更に、亜鉛化合物としては溶解度が0.1
g/100ml以上のものであれば特に限定されるもの
ではなく、具体的には、例えば硫酸亜鉛、グルコン酸亜
鉛、亜鉛を含むカキ肉エキス等の貝の抽出エキスや海藻
の抽出エキス等が挙げられる。Further, as a zinc compound, the solubility is 0.1.
It is not particularly limited as long as it is g / 100 ml or more, and specific examples thereof include extract of shellfish such as zinc sulfate, zinc gluconate, and oyster meat extract containing zinc, and extract of seaweed. To be
【0029】また、そばの葉や大麦の葉、特にこれらの
若葉の抽出エキス等の植物からのエキスもカルシウムや
マグネシウムを含んでおり、有用に利用できるものであ
る。Further, plant-derived extracts such as buckwheat leaves and barley leaves, especially extracts of these young leaves, contain calcium and magnesium and can be usefully utilized.
【0030】そして、本発明の健康飲料においては、抹
消の血管を強化したり、高血圧や酸化防止等の有用な作
用を持つと言われており、しかも安全性の高いケルセチ
ンの配糖体に、体液の浸透圧の保持や酸アルカリ平衡等
の電解質バランスに影響を与え、しかも筋肉神経の刺激
伝達などの生理機能調整物質であるミネラルのうち、ケ
ルセチン配糖体と錯体を形成する等の相互作用を有する
2価の金属イオンである、カルシウム、マグネシウム、
亜鉛を含有させてなるものに、加えて、アルコール代謝
を促進してその負担を緩和し、且つ肝障害抑制やミクロ
ゾーム系の代謝酵素、又は細胞膜等に作用してエタノー
ルやアセトアルデヒドによる障害を抑制すると言われて
いるグリチルリチンを含む甘草抽出物を含有させると、
驚くべきことに、これら成分の相互作用によって、飲酒
による酔い過ぎ、悪酔い、二日酔いの予防や防止を効果
的に図ることができるのである。In the health drink of the present invention, it is said that it has useful actions such as strengthening peripheral blood vessels, high blood pressure and antioxidant, and is a highly safe glycoside of quercetin, Interactions such as formation of complexes with quercetin glycosides among minerals that affect the retention of osmotic pressure of body fluids and electrolyte balance such as acid-alkali equilibrium, and are substances that regulate physiological functions such as stimulus transmission of muscle nerves Calcium, magnesium, which is a divalent metal ion having
In addition to those containing zinc, in addition to promoting alcohol metabolism to alleviate the burden, and also to suppress liver damage and microsomal metabolic enzymes, or cell membranes and other damages caused by ethanol or acetaldehyde. When the licorice extract containing the so-called glycyrrhizin is contained,
Surprisingly, the interaction of these components can effectively prevent or prevent excessive sickness, sickness, and hangover from drinking.
【0031】ところで、甘草は、中国北部に自生するマ
メ科の多年草であり、根を用いるのであるが、特殊な甘
味を持っているため近縁植物を含めて、矯味剤や甘味剤
として、古くから味噌や醤油の甘味料、その他種々の食
品の矯味剤や甘味料として食品分野で、又、同様に医薬
品分野でも矯味剤や甘味剤その他の目的で広く用いられ
てきた安全性の高いものである。By the way, licorice is a perennial of the legume family that grows naturally in northern China and uses roots. However, because it has a special sweetness, it has long been used as a corrigent or sweetener, including related plants. It is a highly safe product that has been widely used in the food field as a sweetener for miso and soy sauce, and as a flavoring agent and sweetener for various other foods, and also in the pharmaceutical field for other purposes such as a flavoring agent, a sweetener, and the like. is there.
【0032】本発明で用いられるのは、この甘草から種
々の方法によって抽出した、甘草抽出物であって、特
に、主成分のグリチルリチンの含有量で品質を確保した
抽出物が使いやすく好ましい。What is used in the present invention is a licorice extract extracted from this licorice by various methods. Particularly, an extract whose quality is secured by the content of glycyrrhizin as a main component is easy to use and preferred.
【0033】また、グリチルリチンは遊離の形のもので
あるので、通常の健康飲料においては水に難溶であるの
で、公知の方法で、シクロデキストリンで包摂し、可溶
性にさせたものを用いることが好ましいのである。Further, since glycyrrhizin is in a free form, it is hardly soluble in water in normal health drinks. Therefore, it is preferable to use glycyrrhizin which is solubilized by inclusion with cyclodextrin by a known method. It is preferable.
【0034】このグリチルリチンが体内で1分子加水分
解して、2分子のグルクロン酸を生成して、これが解毒
作用、つまり強力に毒素と抱合体を形成すること等によ
って毒素による体内への悪影響を防止するとともに、副
腎皮質ホルモン増強作用、脱コレステロール作用及び動
脈硬化抑制作用、又、アルコールの代謝及び消失を促進
し、更に肝臓機能向上及び保護作用等を発現するのであ
る。This glycyrrhizin hydrolyzes one molecule in the body to produce two molecules of glucuronic acid, which prevents detoxification, that is, the adverse effect of the toxin on the body by strongly forming a conjugate with the toxin. In addition, it enhances adrenocortical hormones, decholesterolemia and arteriosclerosis, promotes metabolism and disappearance of alcohol, and further improves liver function and protects the liver.
【0035】このように、ケルセチン配糖体、2価の金
属イオンとグリチルリチンを含んだ甘草抽出物からなる
健康飲料を飲用すれば、体内においてこれらの相互作用
によって、摂取する各成分量は少量であっても、驚くべ
きことに、酔い過ぎ、悪酔い、二日酔いを防止できるこ
とはもとより、飲酒前或いは飲酒直前に飲用しておけ
ば、今までの飲酒時の状態とは全く異なり、酔いが少な
く著しく酩酊状態が改善されるのであり、その上、酒に
対する味覚には何ら変化がないことが認められた。As described above, when a healthy drink comprising a quercetin glycoside, a licorice extract containing divalent metal ions and glycyrrhizin is consumed, the amount of each component ingested by the interaction between them is small. Even so, surprisingly, it is possible to prevent excessive sickness, sickness, and hangover, and if you take it before or just before drinking, it will be drastically less drastic than the state when drinking before, and drunken drastically It was found that the condition was improved, and moreover that there was no change in the taste of sake.
【0036】本発明の健康飲料は上述の成分を必須とす
るものであるが、所望により種々の水溶性添加剤を含有
させることによって飲用時の味覚や感覚を向上させ、更
に栄養を強化しても良いのである。The health drink of the present invention contains the above-mentioned components as essential components. However, if desired, various water-soluble additives may be added to improve the taste and sensation during drinking and further enhance nutrition. Is also good.
【0037】この目的として、例えば、白糖、果糖、ブ
ドウ糖、オリゴ糖、フラクトオリゴ糖、麦芽糖、ステビ
ア、蜂蜜、塩化ナトリウム、塩化カリウム、グリセリ
ン、デキストリン、CMC、アルギン酸、アラギアゴム
末、アミノ酸、ビタミン類、椎茸エキス、クチナシエキ
ス、梅肉エキス、レモン等の柑橘類のエキス、香料、等
の甘味剤、矯味剤、溶剤、増粘剤、着香剤、更に防腐
剤、界面活性剤、健康増進剤、肝臓の機能に有用な天然
物等の水溶性添加剤を含有しても良いのである。For this purpose, for example, sucrose, fructose, glucose, oligosaccharides, fructooligosaccharides, maltose, stevia, honey, sodium chloride, potassium chloride, glycerin, dextrin, CMC, alginic acid, alagia gum powder, amino acids, vitamins, shiitake mushrooms. Extract, gardenia extract, plum extract, citrus extract such as lemon, flavoring agents, sweeteners, flavoring agents, solvents, thickeners, flavoring agents, preservatives, surfactants, health enhancers, liver It may contain a water-soluble additive such as a natural product useful for the function.
【0038】本発明の健康飲料は、飲酒に対して飲用す
るものであるが、1回の飲用量が容易に分かるように、
小分して遮光ガラス瓶等の容器に密封したものが至極便
利であると同時に、外界の空気を遮断することによって
変質を防ぐことができるのである。この場合、1回量と
しては、25〜100mlの飲用量が一般的である。The health drink of the present invention is to be drunk for drinking, but it is possible to easily understand a single dose.
It is extremely convenient to divide it into small parts and seal them in a container such as a light-shielding glass bottle, and at the same time, it is possible to prevent alteration by blocking the outside air. In this case, a dose of 25 to 100 ml is generally used as a single dose.
【0039】本発明の健康飲料においては、各成分の配
合割合は、効果を発現する所望の割合であれば、特に限
定するものではない。In the health drink of the present invention, the blending ratio of each component is not particularly limited as long as it is a desired ratio to exert the effect.
【0040】本発明の健康飲料は、上述の飲料において
その配合割合が、ケルセチン配糖体(A)がルチン換算で
0.005〜1重量%、2価の金属イオン(B)が0.0
01〜1重量%と甘草抽出物(C)がその有効成分である
グリチルリチンとして0.005〜0.5重量%である
ものが有益である。The health drink of the present invention contains 0.005 to 1% by weight of quercetin glycoside (A) in terms of rutin and 0.02% of divalent metal ion (B) in the above drink.
It is useful that the licorice extract (C) is glycyrrhizin as an active ingredient in an amount of 0. 01 to 1% by weight and 0.005 to 0.5% by weight.
【0041】上記(A)成分の含有量が0.005重量%
未満になると、当該健康飲料の成分の相乗効果を充分に
生かすことができないことがあり、効果が乏しくなり、
一方、1重量%以上になると、上記(B)及び(C)成分と
のバランスが崩れて、相乗効果が乏しくなり、悪酔いや
二日酔い等に対する効果が乏しくなる恐れがあるので好
ましくない。これらの理由により、上記(A)成分の含有
量が、特にルチン換算で0.01〜0.5重量%とする
のが望ましい。The content of the component (A) is 0.005% by weight.
If it is less than, the synergistic effect of the components of the health drink may not be able to be fully utilized, and the effect becomes poor,
On the other hand, if it is 1% by weight or more, the balance with the above-mentioned components (B) and (C) is disturbed, the synergistic effect becomes poor, and the effect on sickness, hangover, etc. may become poor, which is not preferable. For these reasons, the content of the component (A) is preferably 0.01 to 0.5% by weight in terms of rutin.
【0042】ここにおいて、上記(A)成分配合割合を定
めるにあたり、ルチン換算としたのは以下の理由によ
る。即ち、ケルセチン配糖体において、配糖体の糖の種
類によって分子量が異なるのであり、これらの糖は健康
飲料に対して、ケルセチン配糖体を水溶性の成分として
提供するものであり、しかもいずれのケルセチン配糖体
も体内ではケルセチンと糖とに分解するのであり、ケル
セチン配糖体として最も代表的な成分であり、汎用され
ているルチンを基本として、換算するのが、本発明の目
的に合致するからである。Here, the rutin conversion is used to determine the component (A) blending ratio for the following reason. That is, in quercetin glycosides, the molecular weight varies depending on the type of sugar in the glycoside, and these sugars provide quercetin glycoside as a water-soluble component to health drinks, and The quercetin glycoside of is also decomposed into quercetin and sugar in the body, which is the most representative component as the quercetin glycoside, and it is the purpose of the present invention to convert it based on rutin which is widely used. Because they match.
【0043】又、上記(B)において、2価の金属イオン
が、0.001重量%未満となると、配合する意義が少
なくなるとともに、上記成分(A)との相互作用が期待で
きなくなるので、悪酔いや二日酔いに対する効果が乏し
くなる恐れがあり、一方、1重量%を超えると、本発明
の健康飲料の目的としては過剰量になり、不経済である
とともに、これら金属イオンによって健康飲料中の成分
に影響を与えて沈澱を起こしたり、又、健康飲料の風味
が悪くなる恐れ等が生じるので好ましくない。Further, in the above (B), when the content of the divalent metal ion is less than 0.001% by weight, the significance of blending becomes small and the interaction with the above component (A) cannot be expected. There is a risk that the effect on sickness and hangover may be poor, while if it exceeds 1% by weight, it will be an excessive amount for the purpose of the health drink of the present invention, it is uneconomical, and these metal ions cause the components in the health drink to be contained. It is not preferable because it may affect precipitation and cause precipitation, or the flavor of a healthy beverage may be deteriorated.
【0044】これらの理由により、上記(B)成分の含有
量が、0.002〜0.5重量%の範囲とするのが好ま
しい。For these reasons, the content of the component (B) is preferably in the range of 0.002 to 0.5% by weight.
【0045】又、上記(C)成分の含有量において、その
有効成分であるグリチルリチンの含有量が0.005重
量%未満になるとグリチルリチンそのものの効果が乏し
くなったり、上記(A)及び(B)成分とのバランスが崩れ
相互作用が乏しくなる結果、悪酔いや二日酔い等に対す
る効果が期待できなくなる恐れがあり、一方、0.5重
量%を超えると、上記(A)及び(B)成分とのバランスが
崩れるとともに、風味が低下する等、健康飲料としての
価値が減少するだけでなく、沈澱等の濁りが生じる恐れ
が生じるので好ましくない。Further, in the content of the component (C), when the content of glycyrrhizin which is the effective component thereof is less than 0.005% by weight, the effect of glycyrrhizin itself becomes poor, or the above (A) and (B). As a result, the balance with the ingredients is lost and the interaction becomes poor, so there is a risk that the effects on sickness, hangover, etc. may not be expected. On the other hand, when it exceeds 0.5% by weight, the balance with the above-mentioned components (A) and (B) Is not preferable because not only the value of the beverage as a health drink decreases, such as the deterioration of flavor and the flavor, but also cloudiness such as precipitation may occur.
【0046】従って、上記(C)成分の配合割合としては
その有効成分であるグリチルリチンとしての含有量が、
特に0.01〜0.3重量%のものが望ましい。Therefore, the content of glycyrrhizin which is the effective component of the above component (C) is as follows:
Particularly, 0.01 to 0.3% by weight is desirable.
【0047】このように、この健康飲料において、上記
(C)成分の配合割合を定めるにあたり、その有効成分で
あるグリチルリチンの割合で決定するのは以下の理由に
よる。As described above, in this health drink,
In determining the blending ratio of the component (C), the ratio of glycyrrhizin, which is the active ingredient, is used for the following reasons.
【0048】即ち、甘草は天然物であるので、有効成分
であるグリチルリチン含有量が約2〜5重量%と種々の
グレードのものがあり、又、甘草に由来する抽出物にお
いて種々の成分が混在する。従って、その有効成分であ
るグリチルリチンを指標物質とすることが、本発明の目
的を達成する上で至極重要だからである。That is, since licorice is a natural product, there are various grades of glycyrrhizin, which is an active ingredient, of about 2 to 5% by weight, and various components are mixed in the extract derived from licorice. To do. Therefore, the use of glycyrrhizin, which is the active ingredient thereof, as an indicator substance is extremely important in achieving the object of the present invention.
【0049】本発明の上記健康飲料においては、水溶性
のケルセチン配糖体に代えて、ルチンをシクロデキスト
リンで包摂して水に可溶な形にしたものを用いることが
できる。In the above health drink of the present invention, a water-soluble form can be used in which rutin is included in cyclodextrin in place of the water-soluble quercetin glycoside.
【0050】即ち、健康飲料は変質を防いだり味覚を爽
やかにする等の理由で、その水溶液として、酸性である
のが一般的であり、一方酸性水溶液にはルチンは難溶で
あるので、ケルセチン配糖体のうちで最も入手しやすく
汎用されているルチンを有効に用いるためには、上記の
ような可溶な形にすることが望ましいのである。That is, a health drink is generally acidic as an aqueous solution thereof for the purpose of preventing deterioration and refreshing the taste, while rutin is hardly soluble in the acidic aqueous solution. In order to effectively use rutin, which is the most readily available glycoside and is widely used, it is desirable to use the soluble form as described above.
【0051】ルチンをシクロデキストリンで包摂する方
法としては、公知の方法でよいのである。A known method may be used as a method of incorporating rutin with cyclodextrin.
【0052】更に、甘草抽出物の有効成分であるグリチ
ルリチンは、酸性物質であり、酸性水溶液においては遊
離の酸として存在し、溶解性が悪い等の理由で、上記ル
チンと同様にシクロデキストリン包摂体を用いることが
できる。Further, glycyrrhizin, which is an active ingredient of licorice extract, is an acidic substance, exists as a free acid in an acidic aqueous solution, and is poor in solubility. Can be used.
【0053】甘草抽出物をシクロデキストリンで包摂す
る方法としては、公知の方法でよいのである。As a method for incorporating the licorice extract with cyclodextrin, a known method may be used.
【0054】本発明の上記健康飲料においては、当該飲
料の成分として上述の種々の添加剤が含有されたものも
含まれるが、この添加剤の配合割合はその配合目的を達
成する所望の量でよいのであり、これによって健康飲料
の風味を良くし飲用しやすくしたり、機能を向上させる
ことができるのである。The health drink of the present invention includes those containing the above-mentioned various additives as components of the drink, and the mixing ratio of the additives is a desired amount for achieving the mixing purpose. This is good, and this makes it possible to improve the flavor of healthy drinks, make them easier to drink, and improve their functions.
【0055】更に、上記健康飲料を小分して遮光性ガラ
ス瓶等の容器に密封することによって、外界の空気を遮
断し、紫外線の影響を防ぐことによって変質を防止する
ことができるのと同時に、1回の飲用量が容易に分かる
ので至極便利である。Furthermore, by subdividing the above-mentioned healthy drink into small containers and sealing them in a container such as a light-shielding glass bottle, the outside air can be shut off and the influence of ultraviolet rays can be prevented to prevent deterioration. It is extremely convenient because you can easily know the dose of one dose.
【0056】本発明においては、ケルセチン配糖体(A)
と、2価の金属イオン(B)及び甘草抽出物(C)にビタミ
ンC及び/又は有機酸(D)を必須成分とするものが特に
有益である。In the present invention, quercetin glycoside (A)
In addition, a divalent metal ion (B) and a licorice extract (C) containing vitamin C and / or an organic acid (D) as essential components are particularly useful.
【0057】本発明においては、上述の健康飲料にビタ
ミンC及び/又は有機酸を含有させたものであり、ここ
で用いられる上記(A)、(B)及び(C)の成分は上述の健
康飲料と同様なので重複説明を避けるために省略する。In the present invention, the above-mentioned health drink contains vitamin C and / or organic acid, and the components (A), (B) and (C) used here are the above-mentioned health drinks. Since it is the same as the beverage, it is omitted to avoid redundant explanation.
【0058】このように、上述の健康飲料に成分(D)の
うち、ビタミンCを含有させると、当該健康飲料中のケ
ルセチン配糖体の安定性や吸収性が向上して、ケルセチ
ン配糖体による末梢血管強化等の効果が一層向上するの
である。As described above, when vitamin C among component (D) is contained in the above-mentioned health drink, stability and absorbability of quercetin glycoside in the health drink are improved, and quercetin glycoside is improved. The effect of strengthening peripheral blood vessels and the like is further improved.
【0059】更に、ビタミンCは、利尿作用を促進し、
生体内の毒素を早期に体外に放出して生体の活動を正常
に回復させる機能を有するのである。Further, vitamin C promotes a diuretic action,
It has the function of releasing the toxin in the living body to the outside of the body early to restore the normal activity of the living body.
【0060】又、上述の健康飲料に成分(D)のうち、有
機酸を含有させた健康飲料において、有機酸を含有し、
且つそのpHが3〜5であると、当該健康飲料中のケル
セチン配糖体の安定性や吸収性が向上する上、吸収され
て細胞の賦活を促進するのであり、更に有機酸の存在に
よって、ケルセチン配糖体やビタミンCの安定性が増強
されるのである。Further, in the health drink containing the organic acid among the components (D) in the health drink, the organic acid is contained in the health drink,
And, if the pH is 3 to 5, the stability and absorbability of the quercetin glycoside in the health drink are improved, and it is absorbed to promote cell activation, and the presence of an organic acid further The stability of quercetin glycosides and vitamin C is enhanced.
【0061】ここで用いられる有機酸としては食用に供
しうる有機の酸性物質であれば特に限定されるものでは
なく、具体的な代表例としては、例えばクエン酸、リン
ゴ酸、或いは酒石酒等が挙げられるのであり、これらは
単独或いは2種以上併用できる。The organic acid used here is not particularly limited as long as it is an organic acidic substance which can be used for food, and specific representative examples thereof include citric acid, malic acid, tartar liquor and the like. These may be used alone or in combination of two or more.
【0062】この有機酸のうち、特にクエン酸は体内で
乳酸や焦性ブドウ酸等を分解させ、血液の酸性化を防止
する点から好ましい。Of these organic acids, citric acid is particularly preferable because it decomposes lactic acid, pyrogluconic acid and the like in the body to prevent acidification of blood.
【0063】又、この健康飲料は上述の場合と同様に、
種々の添加剤を含有させることにより、健康飲料の風味
を良くし飲用しやすくしたり機能を向上させることがで
きるのである。Also, this health drink is similar to the above case,
By including various additives, it is possible to improve the flavor of health drinks, make them easier to drink, and improve their functions.
【0064】更に、上記の場合と同様に、遮光瓶に小分
けをして変質を防止する等の措置を講じるのが好ましい
のである。Further, as in the above case, it is preferable to take measures such as subdividing the light-shielding bottle to prevent alteration.
【0065】本発明の健康飲料においては、各成分の配
合割合は、効果を現す所望の割合であれば、特に限定す
るものではない。In the health drink of the present invention, the compounding ratio of each component is not particularly limited as long as it is a desired ratio exhibiting an effect.
【0066】本発明の健康飲料は、上記飲料において各
成分の配合割合が、ケルセチン配糖体(A)がルチン換算
で0.005〜1重量%、2価の金属イオン(B)が0.
001〜1重量%と甘草抽出物(C)がその有効成分であ
るグリチルリチンとして0.005〜0.5重量%、及
びビタミンC及び/又は有機酸(D)0.01〜2重量
%が含有されているものが至極有益である。In the health drink of the present invention, the blending ratio of each component in the above drink is 0.005 to 1% by weight of the quercetin glycoside (A) in terms of rutin and 0.2% of the divalent metal ion (B).
001 to 1% by weight, licorice extract (C) as an active ingredient, glycyrrhizin 0.005 to 0.5% by weight, and vitamin C and / or organic acid (D) 0.01 to 2% by weight. What is done is extremely useful.
【0067】本発明の健康飲料において、上記の(A)、
(B)及び(C)の成分を特定した理由は、上述の健康飲料
の場合と同様なので重複説明を避けるために省略する。In the health drink of the present invention, the above (A),
The reason why the components (B) and (C) are specified is the same as in the case of the health drink described above, and therefore the description thereof is omitted to avoid redundant description.
【0068】又、ここで上記(D)成分を特定した理由
は、以下の通りである。即ち、上述の通り、上記(D)の
成分のうち、ビタミンCは健康飲料中のケルセチン配糖
体の安定性や吸収性を向上させ、ケルセチン配糖体によ
る末梢血管強化等効果が一層向上するのであり、更に、
利尿作用を促進し、生体内の毒素を早期に体外へ放出す
る等、アルコールによって低下した生体の機能を正常に
回復させるのである。The reason why the component (D) is specified here is as follows. That is, as described above, among the components of (D) above, vitamin C improves the stability and absorbability of quercetin glycosides in health drinks, and the effects of quercetin glycosides such as strengthening of peripheral blood vessels are further improved. And, in addition,
It promotes the diuretic action, releases toxins in the living body out of the body at an early stage, and restores the functions of the living body that have been reduced by alcohol to normal.
【0069】一方、上記(D)の成分のうち、有機酸を含
有させると、当該健康飲料中のケルセチン配糖体の安定
性や吸収性が向上する上、吸収されて細胞の賦活を促進
するのであり、更に有機酸の存在によって、ケルセチン
配糖体やビタミンCの安定性が増強されるのである。On the other hand, when the organic acid is contained in the component (D), the stability and absorbability of the quercetin glycoside in the health drink are improved, and at the same time, it is absorbed to promote cell activation. Furthermore, the presence of organic acids enhances the stability of quercetin glycosides and vitamin C.
【0070】ところが、本発明の健康飲料においては、
上記(D)の成分についてビタミンC及び/又は有機酸が
0.01重量%未満になると、ケルセチン配糖体の安定
性や吸収性が不十分になって相乗効果が乏しくなる恐れ
があるだけでなく、細胞の賦活作用を促進できない場合
があるほか、健康飲料が所望の酸性度を得ることができ
ない等の問題が生じ、一方、ビタミンC及び/又は有機
酸が2重量%を超えると(A)、(B)及び(C)の成分等の
他成分とのバランスが崩れ、風味や飲用感が低下し飲料
としての価値が減少するとともに、酸性度が強くなり過
ぎて、成分の沈澱や飲料に混濁を生じる恐れがあるので
好ましくない。However, in the health drink of the present invention,
If the content of vitamin C and / or organic acid in the component (D) is less than 0.01% by weight, the stability and absorptivity of quercetin glycoside may be insufficient and the synergistic effect may be poor. In some cases, it may not be possible to promote the cell activation action, and other problems such as a healthy beverage not being able to obtain a desired acidity, while vitamin C and / or organic acids exceeding 2% by weight (A ), (B) and (C) are out of balance with other ingredients such as flavor and drinkability to reduce the value as a beverage, and the acidity becomes too strong, resulting in precipitation of ingredients and beverages. It is not preferable because it may cause turbidity.
【0071】従って、上記(D)成分においてその含有量
が、特にビタミンC及び/又は有機酸0.05〜1重量
%とするのが望ましい。Therefore, the content of the component (D) is preferably 0.05 to 1% by weight of vitamin C and / or organic acid.
【0072】本発明においては、上記健康飲料におい
て、当該健康飲料中に上述の種々の添加剤が含有された
ものも含まれるが、上述と同様なので省略する。又、容
器についても上述と同様なので省略する。In the present invention, the above-mentioned health drink includes those containing the above-mentioned various additives in the health drink, but the description is omitted because it is the same as above. The container is also the same as described above, and will be omitted.
【0073】[0073]
【作用】本発明の健康飲料は、上記構成を有し、ケルセ
チン配糖体と、2価の金属イオン及び甘草抽出物を必須
成分とするものである。ケルセチン配糖体の代表的成分
であるルチンはそば等に含まれている成分で、そばは古
来より長期にわたって幅広い地域で食されてきたもので
あり、又、甘草及び甘草に由来する抽出物も食品や医薬
品の矯味剤や甘味剤として汎用されてきたものであっ
て、いずれも至極安全なものである。The health drink of the present invention has the above-mentioned constitution and contains quercetin glycoside, divalent metal ion and licorice extract as essential components. Rutin, which is a typical component of quercetin glycosides, is a component contained in buckwheat, etc. Soba has been eaten in a wide area for a long time since ancient times, and licorice and extracts derived from licorice are also included. It has been widely used as a corrigent and a sweetener for foods and pharmaceuticals, and all are extremely safe.
【0074】又、ケルセチン配糖体は毛細管性出血の治
療や各種出血の治療に有効であると言われており、且つ
酸化防止作用があるとされているが、該ケルセチン配糖
体が飲酒による血圧の上昇や血液や体液の循環の亢進に
対して、末梢の血管を保護するのであり、又、体液の滲
透圧の保持や酸アルカリ平衡等の電解質バランスに影響
を与え、しかも筋肉神経の刺激伝達などの生理調整物質
であり、更にケルセチン配糖体と錯体を形成する等の相
互作用を有する、2価の金属イオンであるカルシウム、
マグネシウム及び亜鉛のいずれか少なくとも1種を含有
することによって、飲酒による生体の機能の回復を促進
させるのであり、更に、甘草抽出物を含有することによ
って、有効成分のグリチルリチンがアルコールの代謝を
促進してその負担を緩和し、且つ肝障害抑制やミクロゾ
ーム系の代謝酵素、又は細胞膜等に作用してエタノール
やアルデヒドによる障害を抑制し、しかもグリチルリチ
ンが体内で分解して生じたグルクロン酸が、毒素と抱合
体を形成すること等によって解毒作用を発現し、アルコ
ールの代謝及び消失を促進し、又、解毒作用や肝臓機能
向上及び保護作用を示すとともに、胆汁の分泌が促進さ
れるのであり、これらの成分の相乗作用によって、飲酒
に伴う良い過ぎ、悪酔い、二日酔いの予防や防止を効果
的に図り、しかも、安全にいつでも何処でも、飲酒の前
はもとより飲酒に対応して手軽に飲用して悪酔い等に対
応しうる作用を有するのである。Further, quercetin glycosides are said to be effective for the treatment of capillary bleeding and various bleeding and are said to have an antioxidant effect. It protects peripheral blood vessels against the rise in blood pressure and the circulation of blood and body fluids, and also affects the retention of osmotic pressure of body fluids and the electrolyte balance such as acid-alkaline balance, and stimulation of muscle nerves. Calcium, which is a divalent metal ion that is a physiological regulator of transmission, and further has an interaction such as forming a complex with quercetin glycoside,
By containing at least one of magnesium and zinc, the recovery of biological functions due to drinking is promoted, and by containing licorice extract, the active ingredient glycyrrhizin promotes the metabolism of alcohol. The glucuronic acid produced by the decomposition of glycyrrhizin in the body is toxin and toxin, which alleviates the burden and suppresses the damage caused by ethanol and aldehyde by acting on liver damage suppression and microsomal metabolic enzymes, or cell membranes. By forming a conjugate or the like, detoxification is expressed, alcohol metabolism and disappearance are promoted, and detoxification and liver function improvement and protection are shown, and bile secretion is promoted. The synergistic effects of the ingredients effectively prevent and prevent excessive sickness, sickness, and hangovers associated with drinking, and Safe anywhere at any time, it has a function that may correspond to hangovers, etc. and drinking with ease in response to the well drinking before drinking.
【0075】又、本発明の健康飲料において、更にビタ
ミンC及び/又は有機酸を含有させると、該ビタミンC
はケルセチン配糖体の吸収性や安定性を向上させるだけ
でなく、ケルセチン配糖体との相互作用によって、消化
器、循環器において相乗的に効果を発現すのであり、こ
のため、一層アルコール代謝が促進されて飲酒による酔
い過ぎ、悪酔い、二日酔いの一層の防止を図れるととも
に、該有機酸を含有させるとケルセチン配糖体やビタミ
ンCの一層の安定化を図ることができる上、細胞の賦活
を促進する作用を有するのであり、特に、クエン酸を用
いることによって、体内の乳酸や焦性ブドウ酸等を分解
させ、血液の酸性化を防止することができる作用を有す
るのである。When the health drink of the present invention further contains vitamin C and / or an organic acid, the vitamin C
Not only enhances the absorption and stability of quercetin glycosides, but also interacts with quercetin glycosides to exert synergistic effects in the digestive and circulatory organs. Is promoted to prevent excessive sickness, sickness, and hangover due to drinking, and by containing the organic acid, quercetin glycosides and vitamin C can be further stabilized and cell activation can be achieved. In particular, citric acid has the action of promoting the action of decomposing lactic acid and pyrogluconic acid in the body to prevent acidification of blood.
【0076】このように、本発明の健康飲料において
は、驚いたことに、飲酒前に飲用しておけば、今までの
飲酒の状態とはまったく異なり、各成分の量は少なくて
も、酔いが少なく著しく酩酊状態が改善される上、飲酒
による酔い過ぎ、悪酔い、二日酔いの一層の予防及び防
止ができる作用を有するのである。As described above, surprisingly, in the health drink of the present invention, if it is drunk before drinking, it is completely different from the conventional drinking state, and even if the amount of each component is small, it causes sickness. In addition to the fact that the drunkenness is significantly improved, it has the effect of further preventing and preventing excessive sickness, sickness and hangover due to drinking.
【0077】[0077]
【実施例】以下、本発明を実施例に基づき詳細に説明す
るが、本発明はこれに限定されるものではない。 実施例1 α−グリコシルルチン 0.1重量% 乳酸カルシウム 0.2重量% 塩化マグネシウム 0.1重量% 甘草抽出物のシクロデキストリン包摂体 1.5重量% ビタミンC 0.2重量% クエン酸 0.1重量% 精製水 97.8重量%EXAMPLES The present invention will now be described in detail based on examples, but the present invention is not limited thereto. Example 1 α-Glycosyl rutin 0.1% by weight Calcium lactate 0.2% by weight Magnesium chloride 0.1% by weight Cyclodextrin inclusion body of licorice extract 1.5% by weight Vitamin C 0.2% by weight Citric acid 0. 1% by weight Purified water 97.8% by weight
【0078】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0079】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量が4.2重量%のものを用い
た。The cyclodextrin inclusion body of the licorice extract used had a glycyrrhizin content of 4.2% by weight.
【0080】実施例2 ルチンのシクロデキストリン包摂体 0.3重量% 乳酸カルシウム 0.2重量% 硫酸マグネシウム 0.15重量% カキ肉エキス 5.0重量% 甘草抽出物のシクロデキストリン包摂体 1.5重量% ビタミンC 0.2重量% 精製水 92.65重量%Example 2 Cyclodextrin inclusion body of rutin 0.3% by weight Calcium lactate 0.2% by weight Magnesium sulfate 0.15% by weight Oyster meat extract 5.0% by weight Cyclodextrin inclusion body of licorice extract 1.5 % By weight Vitamin C 0.2% by weight Purified water 92.65% by weight
【0081】ルチンのシクロデキストリン包摂体として
は、ルチン含有量が10重量%のものを用いた。又、カ
キ肉エキス中の亜鉛の含有量は0.065重量%であっ
た。As the cyclodextrin inclusion body of rutin, one having a rutin content of 10% by weight was used. The zinc content in the oyster meat extract was 0.065% by weight.
【0082】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量が4.2重量%のものを用い
た。The cyclodextrin inclusion body of the licorice extract used had a glycyrrhizin content of 4.2% by weight.
【0083】実施例3 ルチンのシクロデキストリン包摂体 0.3重量% グルコン酸カルシウム 0.2重量% 塩化マグネシウム 0.15重量% グルコン酸亜鉛 0.1重量% 塩化ナトリウム 0.1重量% 甘草抽出物のシクロデキストリン包摂体 1.5重量% クエン酸 0.2重量% 塩化カリウム 0.1重量% タウリン 1.0重量% 安息香酸ナトリウム 0.001重量% 蜂蜜 3.0重量% ステビア 0.05重量% 精製水 93.299重量%Example 3 Cyclodextrin inclusion body of rutin 0.3% by weight Calcium gluconate 0.2% by weight Magnesium chloride 0.15% by weight Zinc gluconate 0.1% by weight Sodium chloride 0.1% by weight Licorice extract Cyclodextrin inclusion body 1.5% by weight Citric acid 0.2% by weight Potassium chloride 0.1% by weight Taurine 1.0% by weight Sodium benzoate 0.001% by weight Honey 3.0% by weight Stevia 0.05% by weight Purified water 93.299% by weight
【0084】ルチンのシクロデキストリン包摂体として
は、ルチン含有量が10重量%のものを用いた。As the cyclodextrin inclusion body of rutin, one having a rutin content of 10% by weight was used.
【0085】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量が4.2重量%のものを用い
た。The cyclodextrin inclusion body of the licorice extract used had a glycyrrhizin content of 4.2% by weight.
【0086】実施例4 α−グリコシルルチン 0.1重量% そばの葉の水抽出エキス 2.0重量% 甘草抽出物のシクロデキストリン包摂体 0.8重量% ビタミンC 0.2重量% クエン酸 0.1重量% 精製水 96.8重量%Example 4 α-Glycosyl rutin 0.1% by weight Water extract of buckwheat leaf 2.0% by weight Cyclodextrin inclusion body of licorice extract 0.8% by weight Vitamin C 0.2% by weight Citric acid 0 .1% by weight Purified water 96.8% by weight
【0087】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0088】そばの葉の水抽出エキスは、水1000ml
にそばの葉の乾燥粉末100gを加えて、時々かき混ぜ
ながら30℃で2日間滲出し、減圧濾過を行って得られ
た抽出水溶液を減圧にて濃縮して200mlとし、再び濾
過して得られた溶液を濃縮して50mlの水抽出エキスを
得た。このエキス中にはカルシウム3.6重量%、マグ
ネシウム1.7重量%が含有されていたが、ルチンは検
出されなかった。The water extract of buckwheat leaf is 1000 ml of water.
To 100 g of dried buckwheat leaf powder was added, and the mixture was leached at 30 ° C. for 2 days with occasional stirring, and the aqueous extract solution obtained by vacuum filtration was concentrated under reduced pressure to 200 ml and filtered again. The solution was concentrated to obtain 50 ml of water extract. This extract contained 3.6% by weight of calcium and 1.7% by weight of magnesium, but rutin was not detected.
【0089】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量が4.2重量%のものを用い
た。The cyclodextrin inclusion body of the licorice extract used had a glycyrrhizin content of 4.2% by weight.
【0090】実施例5 α−グリコシルルチン 0.3重量% 乳酸カルシウム 0.2重量% 甘草エキス 3.0重量% グリセリン 8.0重量% 白糖 2.0重量% 精製水 86.5重量%Example 5 α-Glycosyl rutin 0.3% by weight Calcium lactate 0.2% by weight Licorice extract 3.0% by weight Glycerin 8.0% by weight Sucrose 2.0% by weight Purified water 86.5% by weight
【0091】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0092】甘草エキスは、グリチルリチン含量が3.
5重量%のものを用いた。The licorice extract has a glycyrrhizin content of 3.
5% by weight was used.
【0093】実施例6 α−グリコシルルチン 0.3重量% 塩化マグネシウム 0.2重量% 甘草エキス 1.5重量% グリセリン 8.0重量% 白糖 1.0重量% 精製水 89.0重量%Example 6 0.3% by weight of α-glycosyl rutin Magnesium chloride 0.2% by weight Licorice extract 1.5% by weight Glycerin 8.0% by weight Sucrose 1.0% by weight Purified water 89.0% by weight
【0094】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0095】甘草エキスは、グリチルリチン含量が3.
5重量%のものを用いた。The licorice extract has a glycyrrhizin content of 3.
5% by weight was used.
【0096】比較例1 α−グリコシルルチン 0.3重量% 塩化マグネシウム 0.2重量% 乳酸カルシウム 0.2重量% グリセリン 8.0重量% 白糖 1.0重量% 精製水 90.3重量%Comparative Example 1 α-Glycosyl rutin 0.3% by weight Magnesium chloride 0.2% by weight Calcium lactate 0.2% by weight Glycerin 8.0% by weight Sucrose 1.0% by weight Purified water 90.3% by weight
【0097】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0098】比較例2 塩化マグネシウム 0.2重量% 乳酸カルシウム 0.2重量% 甘草抽出物のシクロデキストリン包摂体 1.5重量% グリセリン 8.0重量% 白糖 1.0重量% 精製水 89.1重量%Comparative Example 2 Magnesium chloride 0.2% by weight Calcium lactate 0.2% by weight Cyclodextrin inclusion body of licorice extract 1.5% by weight Glycerin 8.0% by weight Sucrose 1.0% by weight Purified water 89.1 weight%
【0099】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量は4.2重量%のものを用い
た。The cyclodextrin inclusion body of the licorice extract used had a glycyrrhizin content of 4.2% by weight.
【0100】比較例3 α−グリコシルルチン 0.3重量% 甘草エキス 3.0重量% グリセリン 8.0重量% 白糖 1.0重量% 精製水 87.7重量%Comparative Example 3 α-Glycosyl rutin 0.3% by weight Licorice extract 3.0% by weight Glycerin 8.0% by weight Sucrose 1.0% by weight Purified water 87.7% by weight
【0101】甘草エキスは、グリチルリチン含量が3.
5重量%のものを用いた。The licorice extract has a glycyrrhizin content of 3.
5% by weight was used.
【0102】比較例4 α−グリコシルルチン 0.3重量% 甘草抽出物のシクロデキストリン包摂体 1.5重量% グリセリン 8.0重量% 白糖 1.0重量% ビタミンC 0.2重量% クエン酸 0.1重量% 精製水 88.9重量%Comparative Example 4 α-Glycosyl rutin 0.3% by weight Cyclodextrin inclusion body of licorice extract 1.5% by weight Glycerin 8.0% by weight Sucrose 1.0% by weight Vitamin C 0.2% by weight Citric acid 0 .1% by weight Purified water 88.9% by weight
【0103】α−グリコシルルチン、即ち水溶性ルチン
はルチン換算としてその含量が40重量%のものを用い
た。このものはルチンに1〜4個のグルコースが付加さ
れた混合物である。The α-glycosyl rutin, that is, the water-soluble rutin, had a content of 40% by weight in terms of rutin. This is a mixture of rutin with 1 to 4 glucose added.
【0104】甘草抽出物のシクロデキストリン包摂体は
グリチルリチンの含有量が4.2重量%のものを用い
た。As the cyclodextrin inclusion body of the licorice extract, one having a glycyrrhizin content of 4.2% by weight was used.
【0105】なお、上記各実施例及び比較例に用いた、
甘草抽出物及び甘草抽出物のシクロデキストリン包摂体
中のグリチルリチンの含有率は、高速液体クロマトグラ
フ法によって測定したものである。The above-mentioned examples and comparative examples were used.
The content of glycyrrhizin in the licorice extract and cyclodextrin inclusion bodies of the licorice extract was measured by high performance liquid chromatography.
【0106】上記実施例1の健康飲料を用い、38〜5
6才の男子15名に飲酒直前に50g(50ml)飲用させ
た。Using the health drink of Example 1 above, 38 to 5
Fifteen 6-year-old boys drank 50 g (50 ml) immediately before drinking.
【0107】この場合、月例の宴会であり、比較的多量
の酒を飲む機会であった。評価は、今まで同様の飲酒の
機会であって、同様な酒の量或いはそれ以上の酒を飲ん
だ場合の状態と比較した結果を自発的な申告の評価とし
た。In this case, it was a monthly banquet and an opportunity to drink a relatively large amount of sake. The evaluation was made on the occasion of similar drinking until now, and the result of comparison with the situation when drinking the same amount or more of alcohol was used as the evaluation of voluntary declaration.
【0108】この結果、15名中12名までが、今まで
より、酔いの状態が非常に少ないと評価し、しかも、酩
酊状態でなく精神状態がしっかりしており、3名が、今
までより、酔いの状態が少ないと評価し、更に1名にお
いては少々酔いが少ないように感じるが分からないとの
評価を申告した。As a result, up to 12 out of 15 people evaluated that the state of sickness was much less than before, and the mental state was not so drunk, and 3 were more than ever. They evaluated that they had less sickness, and even one of them reported that they felt a little less sick, but did not understand.
【0109】又、15名において、排尿の頻度が高いと
評価し、酒の味については、特にまずくなったという者
はいなかった。Further, 15 persons evaluated that the frequency of urination was high, and no one said that the taste of sake was particularly bad.
【0110】翌朝は何れの者も二日酔いがなく目覚めも
良かったとの申告を行った。The next morning, all reported that they had no hangover and were well awake.
【0111】更に、翌月に同じメンバーで、比較例1に
ついて同様に飲酒に対しての効果を評価した。ここにお
いて前月と同じくらいの飲酒を行ったところ、10名の
者が同量の飲酒を行った場合の酔いの状態と何ら変わら
ないと評価し、5名において、少々酔いが少ないと評価
を行った。Further, in the following month, the same member evaluated the effect on drinking in Comparative Example 1 in the same manner. When we drunk about the same amount as the previous month, we evaluated that 10 people had no difference from the state of sickness when they drank the same amount, and 5 people evaluated that they were slightly sick. It was
【0112】又、翌朝、いわゆる二日酔いである頭痛を
経験したものが3名おり、酒が残った感じがある。気分
が優れなく倦怠感があると申告した者が3名いた。Also, the next morning, there were 3 people who experienced so-called hangover headaches, and there is a feeling that alcohol remains. There were three people who reported feeling unwell and tired.
【0113】更に、実施例2〜6の健康飲料を50g(5
0ml)ずつ各20本、合計100本を製造し、パネラー
20名にランダムに一人当たり5本の健康飲料を提供
し、1回の飲酒に際して、飲酒30分前〜1時間前に1
本を飲んでその効果を自己申告を依頼した。Furthermore, 50 g (5%) of the health drinks of Examples 2-6 were prepared.
20 ml each, total of 100 bottles are produced, 20 panelists are provided with 5 healthy beverages per person at random, and 1 drink is taken 30 minutes to 1 hour before drinking.
I drank a book and asked for a self-report on the effect.
【0114】ここで、健康飲料の飲用を行った者は、飲
酒の機会が多く、更に二日酔いの経験のあるものである
ことを条件とした。Here, it was assumed that those who took healthy drinks had a lot of drinking opportunities and had a hangover experience.
【0115】同様に、比較例1〜4の飲料を50g(50
ml)ずつ各20本、合計80本を製造し、上記のパネラ
ー20名にランダムに一人当たり4本の飲料を提供し、
1回の飲酒に際して、同様に飲酒30分前〜1時間前に
1本を飲んでその効果の自己申告を依頼した。Similarly, 50 g (50 g) of the beverages of Comparative Examples 1 to 4 were prepared.
20 bottles each, totaling 80 bottles, and randomly providing 4 beverages per person to the 20 panelists.
At the time of one drinking, similarly, one bottle was drunk 30 minutes to 1 hour before drinking, and the self-report of the effect was requested.
【0116】なお、パネラーは、31〜65才の男子1
5名、42〜55才の女子5名であり、女子は飲酒の接
待を仕事としている者である。The panelist is a boy 1 aged from 31 to 65 years.
There are 5 women and 5 girls aged 42 to 55 years old, who are the ones whose business is to entertain drinking.
【0117】この結果のまとめは、表1及び表2に示す
通りであった。The results are summarized in Tables 1 and 2.
【0118】[0118]
【表1】 [Table 1]
【0119】表1において、酔いの状態及び尿の頻度は
以下に示す方法で評価した。 酔いの状態 A 酔いが著しく少なく、意識がハッキリしている。 B 酔いが少ない。 C 酔いが少ないように感じられる。 D 変わらない。分からない。 尿の頻度 A 何時もの飲酒の時とは、尿の頻度が多く、量も多
い。 B 何時もの飲酒の時と変わらない。分からない。In Table 1, the state of sickness and the frequency of urine were evaluated by the following methods. State of sickness A: I have very few sickness and I have a clear awareness. B I have little sickness. C Feels like you have less sickness. D No change. I do not understand. Frequency of urine A When drinking alcohol, the frequency of urine is high and the amount is high. B It is the same as when drinking alcohol. I do not understand.
【0120】[0120]
【表2】 [Table 2]
【0121】表2において、翌日の状態1及び翌日の状
態2は以下に示す方法で評価した。 翌日の状態1 A 何時もの飲酒の時と比べて目覚めがよい。 B 何時もの飲酒の時と変わらない。分からない。 翌日の状態2(ひとりが複数項目の評価は、重複して集
計を行った。) A 体調がよい。 B 飲み疲れ等の倦怠感がある。 C アルコールが残っているように感じる。 D 頭痛がする。 E 胃の調子が悪い。In Table 2, State 1 and State 2 of the next day were evaluated by the following methods. State of the next day 1 A Awakens better than when drinking alcohol all the time. B It is the same as when drinking alcohol. I do not understand. State 2 on the next day (One person evaluated multiple items in duplicate.) A: The physical condition is good. B: I feel tired when I am tired of drinking. C I feel like alcohol remains. D I have a headache. E My stomach is not feeling well.
【0122】即ち、実施例2〜4の健康飲料について
は、飲酒による酔い過ぎ、二日酔い等の予防や防止に優
れた効果があり、又、実施例5又は実施例6について
は、飲酒によるそれらに効果があるが、一方、比較例1
〜5の飲料については、効果がないか、効果ある場合が
あっても充分でないことが分かった。That is, the healthy beverages of Examples 2 to 4 had an excellent effect in preventing and preventing excessive sickness, hangover, etc. due to drinking, and in Examples 5 and 6, those drinking Effective, but Comparative Example 1
It was found that the beverages of Nos. 5 to 5 had no effect, or even if they had an effect, they were not sufficient.
【0123】[0123]
【発明の効果】本発明の健康飲料は、上記構成を有し、
当該飲料は上述のとおり、至極安全なものである。又、
ケルセチン配糖体は毛細管性出血の治療や各種出血の治
療に有効であり、且つ酸化防止作用があるとされている
が、該ケルセチン配糖体が飲酒による血圧の上昇や体液
の循環の亢進に対して、末梢の血管を保護するのであ
り、又、体液の滲透圧の保持や酸アルカリ平衡等の電解
質バランスに影響を与え、しかも筋肉神経の刺激伝達な
どの生理調整物質であり、更にケルセチン配糖体と錯体
を形成する等の相互作用を有する、2価の金属イオンで
あるカルシウム、マグネシウム及び亜鉛のいずれか少な
くとも1種を含有することによって、飲酒による生体の
機能の回復を促進させるのであり、更に、甘草抽出物を
含有することによって、有効成分のグリチルリチンがア
ルコールの代謝を促進してその負担を緩和し、且つ肝障
害抑制やミクロゾーム系の代謝酵素、又は細胞膜等に作
用してエタノールやアルデヒドによる障害を抑制するの
であり、しかもグリチルリチンが体内で分解して生じた
グルクロン酸が、毒素と抱合体を形成すること等によっ
て解毒作用を発現し、アルコールの代謝及び消失を促進
し、又、解毒作用や肝臓機能向上及び保護作用を示すと
ともに、胆汁の分泌が促進されるのであり、これらの成
分の相乗効果によって、飲酒に伴う良い過ぎ、悪酔い、
二日酔いの予防や防止を効果的に図り、しかも、安全に
いつでも何処でも、飲酒の前はもとより飲酒に対応して
手軽に飲用して悪酔い等に対応しうる効果を有するので
ある。The health drink of the present invention has the above constitution,
As described above, the beverage is extremely safe. or,
Quercetin glycosides are said to be effective in the treatment of capillary bleeding and various bleeding, and have an antioxidant effect, but the quercetin glycosides increase blood pressure and enhance circulation of body fluids by drinking alcohol. On the other hand, it protects peripheral blood vessels, affects the retention of osmotic pressure of body fluids, the electrolyte balance such as acid-alkali balance, and is a physiological regulator of muscular nerve stimulation transmission. By containing at least one of divalent metal ions, calcium, magnesium and zinc, which have an interaction such as forming a complex with a sugar, it promotes recovery of the function of the living body by drinking. Furthermore, by containing a licorice extract, glycyrrhizin, an active ingredient, promotes the metabolism of alcohol to alleviate the burden, and suppresses liver damage and microzoa. It acts on metabolic enzymes of the system, cell membranes, etc. to suppress damages caused by ethanol and aldehydes, and glucuronic acid produced by decomposition of glycyrrhizin in the body forms a conjugate with a toxin to detoxify. It is expressed, promotes metabolism and disappearance of alcohol, exhibits detoxification and liver function improvement and protection, and promotes bile secretion. Due to the synergistic effect of these components, it is well-known for drinking. , Sickness,
It has the effect of effectively preventing and preventing a hangover, and, in addition, before and after drinking alcohol, it can be easily consumed in response to drinking and can be used to cope with hangover.
【0124】又、本発明の健康飲料において、更にビタ
ミンC及び/又は有機酸を含有させると、該ビタミンC
はケルセチン配糖体の吸収性や安定性を向上させるだけ
でなく、ケルセチン配糖体との相互作用によって、消化
器、循環器において相乗的に効果を現すのであり、この
ため、一層アルコール代謝が促進されて飲酒による酔い
過ぎ、悪酔い、二日酔いの一層の防止を図れるととも
に、該有機酸を含有させるとケルセチン配糖体やビタミ
ンCの一層の安定化を図ることができる上、細胞の賦活
を促進する効果を有するのであり、特に、クエン酸を用
いることによって、体内の乳酸や焦性ブドウ酸等を分解
させ、血液の酸性化を防止することができる効果を有す
るのである。When the health drink of the present invention further contains vitamin C and / or an organic acid, the vitamin C
Not only improves the absorption and stability of quercetin glycosides, but also interacts with quercetin glycosides to exert a synergistic effect on the digestive and circulatory organs, which further improves alcohol metabolism. It is promoted to prevent excessive sickness, sickness and hangover caused by drinking, and when the organic acid is contained, quercetin glycosides and vitamin C can be further stabilized and cell activation can be promoted. In particular, the use of citric acid has the effect of decomposing lactic acid, pyrogluconic acid and the like in the body and preventing acidification of blood.
【0125】このように、本発明の健康飲料において
は、驚いたことに、飲酒前に飲用しておけば、今までの
飲酒の状態とはまったく異なり、各成分の量は少なくて
も、酔いが少なく著しく酩酊状態が改善される上、飲酒
による酔い過ぎ、悪酔い、二日酔いの一層の予防及び防
止ができる効果を有するのである。As described above, surprisingly, in the health drink of the present invention, if it is taken before drinking, it is completely different from the conventional drinking state, and even if the amount of each component is small, it causes a sickness. In addition, the drunkenness is significantly improved, and it is possible to prevent and prevent excessive sickness, sickness and hangover caused by drinking.
【0126】上記のように、本発明の健康飲料は、安全
性が高い飲料であり、手軽に何時でも飲用でき、更に成
分の複合作用及び効果において、飲酒に対応した至極有
用なものである。As described above, the health drink of the present invention is a highly safe drink, can be easily taken at any time, and is extremely useful in responding to drinking due to its combined action and effect.
Claims (7)
ン及び甘草抽出物を必須成分とする健康飲料。1. A health drink comprising a quercetin glycoside, a divalent metal ion and a licorice extract as essential components.
項1に記載の健康飲料。2. The health drink according to claim 1, wherein the glycoside of quercetin is water-soluble.
ンによって包摂されている請求項1に記載の健康飲料。3. The health drink according to claim 1, wherein the glycoside of quercetin is included by cyclodextrin.
シウム又は亜鉛のうち少なくとも1種である請求項1な
いし3のいずれかに記載の健康飲料。4. The health drink according to claim 1, wherein the divalent metal ion is at least one selected from calcium, magnesium and zinc.
なる請求項1ないし4のいずれかに記載の健康飲料。5. The health drink according to claim 1, wherein the licorice extract contains glycyrrhizin.
されている請求項1ないし5のいずれかに記載の健康飲
料。6. The health drink according to claim 1, wherein the licorice extract is included in cyclodextrin.
酸又は酒石酒のうち少なくとも1種を含有してなる請求
項7に記載の健康飲料。7. The health drink according to claim 7, wherein the organic acid contains at least one of vitamin C, citric acid, malic acid and tartar liquor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4196545A JPH0614746A (en) | 1992-06-29 | 1992-06-29 | Health beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4196545A JPH0614746A (en) | 1992-06-29 | 1992-06-29 | Health beverage |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0614746A true JPH0614746A (en) | 1994-01-25 |
Family
ID=16359527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4196545A Pending JPH0614746A (en) | 1992-06-29 | 1992-06-29 | Health beverage |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0614746A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000290186A (en) * | 1999-04-01 | 2000-10-17 | Taisho Pharmaceut Co Ltd | Liquid composition |
US6713091B1 (en) * | 1999-07-05 | 2004-03-30 | Chan Sik Kim | Composition for lowering the concentration of alcohol in blood containing extracts of pepino and method for producing the same |
KR100469809B1 (en) * | 2002-05-28 | 2005-02-02 | 박래옥 | Beverage Composition Comprising Citric acid, Zinc And Albumin |
JP2005041853A (en) * | 2003-07-25 | 2005-02-17 | T Langeland Bjorn | Composition stimulating specific metalloenzyme |
JP2009219394A (en) * | 2008-03-14 | 2009-10-01 | Seizo Fujikawa | Supercooled drink |
JP2012031080A (en) * | 2010-07-29 | 2012-02-16 | House Foods Corp | Recovery agent for symptom of hangover |
WO2013009997A1 (en) * | 2011-07-12 | 2013-01-17 | Burn-Off, Llc | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication |
CN103535709A (en) * | 2012-07-09 | 2014-01-29 | 贾洪章 | Healthcare food for chemical liver injury |
WO2014177989A2 (en) | 2013-04-29 | 2014-11-06 | Chigurupati Technologies Private Limited | Reduced toxicity in alcoholic beverages |
CN105380051A (en) * | 2015-11-11 | 2016-03-09 | 青海甘露饮生物科技有限公司 | Beverage capable of dispelling alcohol effect and protecting liver and preparation method of beverage |
CN107920577A (en) * | 2015-06-19 | 2018-04-17 | 哈沙·奇古鲁帕蒂 | Cooperate with beverage composition for treating dental erosion |
US10022399B1 (en) * | 2015-05-12 | 2018-07-17 | Mark Campbell Force | Nutritional composition for providing relief from wine induced headaches |
JP2019512240A (en) * | 2016-03-10 | 2019-05-16 | アテニオン アーゲーAthenion Ag | Beverage preparation capsules for delivery of solubilizing substances |
-
1992
- 1992-06-29 JP JP4196545A patent/JPH0614746A/en active Pending
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000290186A (en) * | 1999-04-01 | 2000-10-17 | Taisho Pharmaceut Co Ltd | Liquid composition |
US6713091B1 (en) * | 1999-07-05 | 2004-03-30 | Chan Sik Kim | Composition for lowering the concentration of alcohol in blood containing extracts of pepino and method for producing the same |
KR100469809B1 (en) * | 2002-05-28 | 2005-02-02 | 박래옥 | Beverage Composition Comprising Citric acid, Zinc And Albumin |
JP2005041853A (en) * | 2003-07-25 | 2005-02-17 | T Langeland Bjorn | Composition stimulating specific metalloenzyme |
JP2009219394A (en) * | 2008-03-14 | 2009-10-01 | Seizo Fujikawa | Supercooled drink |
JP2012031080A (en) * | 2010-07-29 | 2012-02-16 | House Foods Corp | Recovery agent for symptom of hangover |
US9186350B2 (en) | 2011-07-12 | 2015-11-17 | Gdb Patent Holdings, Llc | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication |
WO2013009997A1 (en) * | 2011-07-12 | 2013-01-17 | Burn-Off, Llc | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication |
US10028991B2 (en) | 2011-07-12 | 2018-07-24 | Gdb Patent Holdings, Llc | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication |
CN103535709A (en) * | 2012-07-09 | 2014-01-29 | 贾洪章 | Healthcare food for chemical liver injury |
WO2014177989A2 (en) | 2013-04-29 | 2014-11-06 | Chigurupati Technologies Private Limited | Reduced toxicity in alcoholic beverages |
US9149491B2 (en) | 2013-04-29 | 2015-10-06 | Harsha Chigurupati | Reduced toxicity in alcoholic beverages |
US10039776B2 (en) | 2013-04-29 | 2018-08-07 | Harsha Chigurupati | Hepato-protective beverage composition |
US10022399B1 (en) * | 2015-05-12 | 2018-07-17 | Mark Campbell Force | Nutritional composition for providing relief from wine induced headaches |
US20180289740A1 (en) * | 2015-05-12 | 2018-10-11 | Mark Campbell Force | Nutritional composition for providing relief from wine induced headaches |
CN107920577A (en) * | 2015-06-19 | 2018-04-17 | 哈沙·奇古鲁帕蒂 | Cooperate with beverage composition for treating dental erosion |
CN105380051A (en) * | 2015-11-11 | 2016-03-09 | 青海甘露饮生物科技有限公司 | Beverage capable of dispelling alcohol effect and protecting liver and preparation method of beverage |
CN105380051B (en) * | 2015-11-11 | 2018-10-16 | 九饮堂生物科技有限公司 | A kind of anti-alcohol and liver-protection beverage and preparation method thereof |
JP2019512240A (en) * | 2016-03-10 | 2019-05-16 | アテニオン アーゲーAthenion Ag | Beverage preparation capsules for delivery of solubilizing substances |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1633209B1 (en) | Weight management beverage | |
KR101433188B1 (en) | Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof | |
WO1999051252A1 (en) | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation | |
JPH0614746A (en) | Health beverage | |
KR100759222B1 (en) | Method for preparing a drink with red ginseng and vinegar | |
JP2003500077A (en) | Methods and compositions for masking mineral tastes | |
AU2002305703B2 (en) | Carbohydrate modifying agent and drinks containing the modifying agent | |
JP2005336078A (en) | Masking agent | |
DE3319575A1 (en) | THERAPEUTICALLY EFFECTIVE COMPOSITIONS, FOOD AND BEVERAGES | |
AU2002305703A1 (en) | Carbohydrate modifying agent and drinks containing the modifying agent | |
JPH0272843A (en) | Mineral supplement containing sugar alcohol | |
JP5162812B2 (en) | Zinc-containing composition for oral administration | |
JPH03168046A (en) | Composition and food containing tea extract | |
JPH07196523A (en) | Solution for internal use containing quercetin glycoside | |
JPH0775536A (en) | Refreshing beverage containing qaercetin glucoside | |
KR100364000B1 (en) | Sports beverage composition and method thereof | |
JP2006028051A (en) | Ameliorant for exhausted feeling at time of rising, composition for ameliorating exhausted feeling at time of rising, and food and beverage for ameliorating exhausted feeling at time of rising, containing them | |
JP2003189816A (en) | Health food using plum fruit and plum seed kernel | |
JP2996313B2 (en) | Functional health food | |
CN113749203A (en) | Beverage with weight reducing effect and preparation method thereof | |
JPH0563147B2 (en) | ||
CN110558397A (en) | Tea leaf and post-processing method thereof, tea leaf extract and preparation method and application thereof | |
JP4407006B2 (en) | Iron compound combination oral solution | |
JP2006061038A (en) | Enzyme-treated royal jelly-containing health drink | |
JPH0698729A (en) | Ginseng extract-containing beverage and its production |